Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
September 30, 2023 11:16 AM 4 min read

Andreessen Horowitz And Others Poured $200 Million Into Startup Health IQ - Now It's Bankrupt

by Aditi Ganguly Benzinga Staff Writer
Follow

Nearly 90% of startups fail. As one of the riskiest alternative investment avenues, retail investors typically steer clear of startups given the risk parameters, while ultra-wealthy people and venture capital firms often choose to invest exclusively in startups. 

Though nine out of 10 startups fail, making a bet on one can quickly make you a millionaire. 

With $35 billion in total assets under management, Silicon Valley-based Andreessen Horowitz is the world's biggest venture capital firm. While it touts its successful investments, including Airbnb Inc., Meta Platforms Inc., formerly Facebook, and Coinbase Global Inc., Andreessen Horowitz has made some poor choices as well. 

Don't Miss:

  • Until 2016 it was illegal for retail investors to invest in high-growth startups. Thanks to changes in federal law, this Kevin O'Leary-Backed Startup Lets You Become a Venture Capitalist With $100
  • Airbnb was worth $47 billion at IPO. This Startup Is Automating The Trillion-Dollar Hospitality Market. AI Startup Looks To Put Airbnb Hosting And Property Management On Autopilot

Potential Unicorn Turned Bankrupt

Life insurance company Health IQ seemed to be a promising startup in the healthcare space after the firm was valued at $450 million in 2019. Andreessen Horowitz led the company's Series C funding worth $34.6 million in 2017. In addition, Health IQ's resilient performance led Andreessen Horowitz to invest $1.9 million in its convertible notes in February last year. 

But the skies turned grey soon after, as Health IQ Co-Founders Munjal Shah and Gaurav Suri initiated layoffs. Five days after the workforce reduction, Shah and Suri received a payout of $42,000 each labeled as "vacation accrual." 

In February, Shah also began receiving a $3,200 biweekly salary as a "special adviser to the CEO." This came at a time when he was involved in developing his next startup Hippocratic AI.

To stay updated with top startup news & investments, sign up for Benzinga's Startup Investing & Equity Crowdfunding Newsletter.

Bankruptcy Declaration 

On Aug. 30, Health IQ filed a Chapter 7 bankruptcy petition at the Delaware federal court. In the filing, the company revealed it had outstanding liabilities totaling $256.7 million owed to lenders, investors and vendors. Total assets documented in the filing amounted to $1.3 million.

"I am very sorry that I lost your money," Shah stated in an email to Health IQ's investors. But Shah drew out over $170,000 in salary and other compensation in the same month he wrote the email. 

The bankruptcy filings reveal that Health IQ has secured debt of $67.5 million supported by collateral and unsecured claims amounting to $189.2 million. In recent months, Health IQ has been repaying a loan to Silicon Valley Bank. According to the documents, Silicon Valley Bank also obtained $4.5 million from selling intellectual property related to Health IQ's artificial intelligence-driven precision Medicare software. 

DASIR LLC is the first priority creditor and is owed $6.5 million, though the value of collateral remains marked as "undetermined." The second priority lender, TriplePoint Venture Growth, is owed $50 million, but the collateral's listed value is $0. The same holds for the third priority creditors, Quote Velocity, claiming it's owed nearly $7 million, and Innovative Employee Solutions, alleging a debt of $3.7 million. 

Despite TriplePoint and Quote Velocity obtaining a prejudgment writ of attachment, which allowed the court to seize some of Health IQ's assets, the collateral's value is still stated as $0. 

This is likely because there won't be any assets remaining to satisfy the secured creditors once DASIR, the first priority lender, has been reimbursed, according to Rob Lemons, an expert in financial restructuring law.

Plethora Of Lawsuits 

Most of Health IQ's creditors have been suing the bankrupt company, as approximately $189.2 million of the life insurance startup's debt was in the form of unsecured liabilities. 

One lawsuit alleged that Shah encouraged Health IQ employees to continue seeking leads from vendors even though he was aware that Health IQ would struggle to make payments. 

On June 22, Health IQ's lawyers cited the company's "inability" to fulfill discovery requests related to the case because of its "current financial condition and limited resources." In an Aug. 30 filing related to the bankruptcy, Health IQ identified 17 breach-of-contract lawsuits as pending. In addition, Health IQ is facing lawsuits alleging fraudulent practices. 

Continued Support From Andreessen 

The founders of the most successful startups often have several ideas that fail. 

It seems like Andreessen has written off its investment in the startup but has continued to maintain its ties with Shah. For the second time, Andreessen Horowitz co-led a $50 million seed funding round for Shah's Hippocratic AI. 

Julie Yoo, a general partner at Andreessen Horowitz, bet money on Hippocratic AI, stating that they were "literally hanging out in our offices when he [Shah] was first ideating his next adventure."

See more on startup investing from Benzinga.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Startups
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter
  • Robinhood democratized stock market investing, but this Startup Investing Platform Beats Robinhood And Webull By A Mile, Letting Anyone Invest In Startups, Collectibles And A New Mini Startups Stock Market
  • Are Wall Street's days numbered? This platform's game-changing solution could disrupt finance forever.
Comments
Loading...